Showing 1 - 7 results of 7 for search 'Mary M. Mullen', query time: 0.03s Refine Results
  1. 1
    Endometrial adenosarcoma in the setting of a germline DICER1 mutation: A case report

    Endometrial adenosarcoma in the setting of a germline DICER1 mutation: A case report by Mary M. Mullen, Laura M. Divine, Ian S. Hagemann, Sheri Babb, Matthew A. Powell

    Published 2017-05-01
    Get full text
    Article
  2. 2
    A rare case of endometrial cancer metastatic to the uveal choroid

    A rare case of endometrial cancer metastatic to the uveal choroid by Stephanie H. Smith, Sri Krishna C. Arudra, Mary M. Mullen, Marguerite Palisoul, Sonika Dahiya, P. Kumar Rao, Premal H. Thaker

    Published 2018-02-01
    Get full text
    Article
  3. 3
    The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer

    The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer by Angelina Carey-Love, Mary M. Mullen, Abigail Zamorano, Stephanie Markovina, Andrea R. Hagemann, Katherine C. Fuh, Premal H. Thaker, David G. Mutch, Matthew A. Powell, Lindsay M. Kuroki

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care

    Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care by Shaina F. Bruce, Bridget Huysman, Jinai Bharucha, L. Stewart Massad, Mary M. Mullen, Andrea R. Hagemann, Katherine C. Fuh, Carolyn K. McCourt, Premal H. Thaker, Dineo Khabele, Matthew A. Powell, David G. Mutch, Lindsay M. Kuroki

    Published 2022-02-01
    Get full text
    Article
  5. 5
    Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

    Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery by Abigail S. Zamorano, Angela L. Mazul, Christine Marx, Mary M. Mullen, Molly Greenwade, L. Stewart Massad, Carolyn K. McCourt, Andrea R. Hagemann, Premal H. Thaker, Katherine C. Fuh, Matthew A. Powell, David G. Mutch, Dineo Khabele, Lindsay M. Kuroki

    Published 2022-12-01
    Get full text
    Article
  6. 6
    Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

    Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer by Michael D. Toboni, Elena Lomonosova, Shaina F. Bruce, Jo’an I. Tankou, Mary M. Mullen, Angela Schab, Alyssa Oplt, Hollie Noia, Danny Wilke, Lindsay M. Kuroki, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, Dineo Khabele, David G. Mutch, Katherine C. Fuh

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival

    Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival by Emilee N. Kotnik, Mary M. Mullen, Nicholas C. Spies, Tiandao Li, Matthew Inkman, Jin Zhang, Fernanda Martins-Rodrigues, Ian S. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Andrea R. Hagemann, Matthew A. Powell, David G. Mutch, Dineo Khabele, Gregory D. Longmore, Elaine R. Mardis, Christopher A. Maher, Christopher A. Miller, Katherine C. Fuh

    Published 2023-07-01
    Get full text
    Article

Search Tools: